Covered recipient · General Payments record
LINDSEY MARIE MOORE
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2024
$2,807.70
- Reported across 217 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $572.54 | 35 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $187.66 | 15 |
| Lilly USA, LLC | $165.70 | 12 |
| ATRICURE, INC. | $109.71 | 1 |
| DEXCOM, INC. | $33.17 | 2 |
| ABBVIE INC. | $16.41 | 1 |
| Astellas Pharma US Inc | $15.35 | 1 |
| Acerta Pharma LLC | $15.35 | 1 |
| PFIZER INC. | $15.26 | 1 |
| TOLMAR, INC. | $13.93 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (35)
Sorted by paying entity, then date · as published by CMS
Program year 2024 202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $16.41 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107686806 | CMS |
| Astellas Pharma US Inc | $15.35 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139469034 | CMS |
| AstraZeneca Pharmaceuticals LP | $15.35 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104549196 | CMS |
| ATRICURE, INC. | $109.71 | 11/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132896954 | CMS |
| Dexcom, Inc. | $16.27 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153374985 | CMS |
| Dexcom, Inc. | $16.90 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153374987 | CMS |
| Lilly USA, LLC | $23.81 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135801070 | CMS |
| Lilly USA, LLC | $12.50 | 01/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135792272 | CMS |
| Lilly USA, LLC | $13.82 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135801072 | CMS |
| Lilly USA, LLC | $9.76 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135801074 | CMS |
| Lilly USA, LLC | $11.83 | 06/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135794134 | CMS |
| Lilly USA, LLC | $11.29 | 06/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135740868 | CMS |
| Lilly USA, LLC | $14.81 | 07/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135792270 | CMS |
| Lilly USA, LLC | $11.03 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135752955 | CMS |
| Lilly USA, LLC | $14.87 | 08/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135799428 | CMS |
| Lilly USA, LLC | $12.14 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135766457 | CMS |
| Lilly USA, LLC | $15.33 | 09/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135740870 | CMS |
| Lilly USA, LLC | $14.51 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135740872 | CMS |
| Novo Nordisk Inc | $10.27 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100631225 | CMS |
| Novo Nordisk Inc | $13.88 | 02/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100303319 | CMS |
| Novo Nordisk Inc | $13.77 | 03/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100578422 | CMS |
| Novo Nordisk Inc | $12.20 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100320076 | CMS |
| Novo Nordisk Inc | $15.35 | 06/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100364565 | CMS |
| Novo Nordisk Inc | $12.11 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100469684 | CMS |
| Novo Nordisk Inc | $13.48 | 08/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100304375 | CMS |
| Novo Nordisk Inc | $10.37 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100346150 | CMS |
| Novo Nordisk Inc | $15.88 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100634323 | CMS |
| Novo Nordisk Inc | $10.15 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100230004 | CMS |
| Novo Nordisk Inc | $9.66 | 10/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100571842 | CMS |
| Novo Nordisk Inc | $17.09 | 10/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100322628 | CMS |
| Novo Nordisk Inc | $6.15 | 11/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100537427 | CMS |
| Novo Nordisk Inc | $11.36 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100579702 | CMS |
| Novo Nordisk Inc | $15.94 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100504005 | CMS |
| PFIZER INC. | $15.26 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131193138 | CMS |
| Tolmar, Inc. | $13.93 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138717580 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.